Shunsuke Fujisawa
Papers
1
Total Citations
2
H-Index
1
About
Shunsuke Fujisawa is a clinician-researcher specializing in pediatric oncology and the long-term sequelae of childhood cancer treatments. His work centers on the intersection of nephroblastoma (Wilms tumor) therapy and the emergence of secondary malignancies, with a particular focus on renal cell carcinoma (RCC) driven by TFE3 gene translocations. In his most cited case report, Fujisawa documented a rare instance of TFE3-rearranged RCC arising in the contralateral kidney of a child previously treated with chemotherapy for nephroblastoma. This contribution is critical for oncologists and pathologists, as it highlights a distinct, therapy-associated secondary neoplasm that is often underrecognized. By reviewing the literature alongside his case, he underscores the need for vigilant long-term surveillance in survivors of childhood nephroblastoma. Though his citation count is modest, the clinical relevance of his findings is substantial, offering a clear warning about the carcinogenic potential of certain chemotherapeutic regimens. Fujisawa’s work serves as an important reference for those studying treatment-induced malignancies and the molecular mechanisms—such as TFE3 translocation—that drive them.
Research Focus
Key Achievements
Top Papers
- 1